view.info.amerisourcebergen.com Open in urlscan Pro
13.111.91.54  Public Scan

URL: https://view.info.amerisourcebergen.com/?qs=e188cf3135c04898e06a57b378375a84cea2f70bc7fadb50af003f3138a814a8ddd7724316a02f3c2b21f75bf75f...
Submission: On January 04 via api from US — Scanned from DE

Form analysis 0 forms found in the DOM

Text Content

View manufacturer, indication, class of trade information and product
information. Additional information found in Prescribing Information.


View this email as a web page
 

January 04, 2022




New product from AmerisourceBergen Specialty Distribution
Your AmerisourceBergen specialty distributor is now authorized for the
product(s) below. This notification of product availability is being sent to all
active customers. Class of trade restrictions may apply.

The product(s) below can be ordered today through ABC Order or your preferred
ordering method.

ABC Order is our convenient, 24/7 online platform designed to simplify your
ordering process. Click here to learn more or request access.




Manufactured by Novartis, LEQVIO® (inclisiran) is a small interfering RNA
(siRNA) directed to PCSK9 (proprotein convertase subtilisin kexin type 9) mRNA
indicated as an adjunct to diet and maximally tolerated statin therapy for the
treatment of adults with heterozygous familial hypercholesterolemia (HeFH) or
clinical atherosclerotic cardiovascular disease (ASCVD), who require additional
lowering of lowdensity lipoprotein cholesterol (LDL-C)

To learn more about Leqvio, see U.S. Full Prescribing Information.

Leqvio can be distributed to the following classes of trade:

 * Hospitals
 * DoD/VA facilities
 * Any Specialty Pharmacy as designated by National Council for Prescription
   Drug Programs (NCPDP) that is not owned (directly or indirectly) or
   affiliated with a Pharmacy Benefit Manager (PBM)


If you're interested in learning more about Leqvio, click the button below and a
member of our team will be in touch soon.

Contact me about ordering Leqvio

AB item # Product Size NDC # 10263889 Leqvio 284 mg/1.5 mL PFS 00078-1000-60




Manufactured by Argenx, VYVGARTTM (efgartigimod) is a neonatal Fc receptor
blocker indicated for the treatment of generalized myasthenia gravis (gMG) in
adult patients who are anti-acetylcholine receptor (AChR) antibody positive.

To learn more about Vyvgart, see U.S. Full Prescribing Information.

Vyvgart can be distributed to all classes of trade except retail pharmacies,
wholesalers/distributors and research centers unless given written approval by
Argenx.

National SPPs and Regional Infusion Providers must be approved by Argenx.


If you're interested in learning more about Vyvgart, click the button below and
a member of our team will be in touch soon.

Contact me about ordering Vyvgart

AB item # Product Size NDC # 10263888 Vyvgart 400 mg/20 mL SDV 73475-3041-05

    SD-100410

click

This email was sent to mekeita.freeman@memorialhermann.org because you have an
account with or are a valued partner of AmerisourceBergen. If you no longer wish
to receive these types of emails, please click here to unsubscribe or update
your email preferences.
Update Profile
AmerisourceBergen - 1 West First Avenue Conshohocken, PA 19428
© 2022 AmerisourceBergen. All Rights Reserved.
x